Literature DB >> 20552238

Investigation of the prevalence of antibodies against neurotropic polyomaviruses BK, JC and SV40 in sera from patients affected by multiple sclerosis.

Tatiana Ribeiro1, Maxime J Fleury, Enrico Granieri, Massimiliano Castellazzi, Fernanda Martini, Elisa Mazzoni, Pierre Coursaget, Mauro Tognon.   

Abstract

Viral agents seem to be linked to multiple sclerosis (MS). This association is based on evidence of (1) early exposure to viruses and MS onset; (2) increased prevalence of MS disease in specific geographic regions; (3) likelihood of developing MS being more prevalent in high-risk areas; (4) altered immune responses to different viruses. In this study, sera from patients affected by MS and controls, represented by sera from patients with other neurologic diseases, both inflammatory and non-inflammatory, and from healthy donors, were investigated for the presence of antibodies against neurotropic polyomaviruses BKV, JCV and SV40 in their sera. Our study has indicated that the prevalence of BKV antibodies in sera from MS patients is higher than that detected in normal individuals, while levels of antibodies against BKV and JCV are lower in MS patients compared to those of normal subjects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20552238     DOI: 10.1007/s10072-010-0353-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  25 in total

Review 1.  Infectious causes of multiple sclerosis.

Authors:  Gavin Giovannoni; Gary R Cutter; Jan Lunemann; Roland Martin; Christian Münz; Subramaniam Sriram; Israel Steiner; Margaret R Hammerschlag; Charlotte A Gaydos
Journal:  Lancet Neurol       Date:  2006-10       Impact factor: 44.182

Review 2.  BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors.

Authors:  Giuseppe Barbanti-Brodano; Silvia Sabbioni; Fernanda Martini; Massimo Negrini; Alfredo Corallini; Mauro Tognon
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

Review 3.  Infections and autoimmune diseases.

Authors:  Jean-François Bach
Journal:  J Autoimmun       Date:  2005-11-08       Impact factor: 7.094

Review 4.  BK and JC human polyomaviruses and simian virus 40: natural history of infection in humans, experimental oncogenicity, and association with human tumors.

Authors:  G Barbanti-Brodano; F Martini; M De Mattei; L Lazzarin; A Corallini; M Tognon
Journal:  Adv Virus Res       Date:  1998       Impact factor: 9.937

5.  Seroepidemiology of the human polyomaviruses.

Authors:  Annika Stolt; Kestutis Sasnauskas; Pentti Koskela; Matti Lehtinen; Joakim Dillner
Journal:  J Gen Virol       Date:  2003-06       Impact factor: 3.891

Review 6.  Simian virus 40 infection in humans and association with human diseases: results and hypotheses.

Authors:  Giuseppe Barbanti-Brodano; Silvia Sabbioni; Fernanda Martini; Massimo Negrini; Alfredo Corallini; Mauro Tognon
Journal:  Virology       Date:  2004-01-05       Impact factor: 3.616

Review 7.  Cell and molecular biology of simian virus 40: implications for human infections and disease.

Authors:  J S Butel; J A Lednicky
Journal:  J Natl Cancer Inst       Date:  1999-01-20       Impact factor: 13.506

8.  High incidence of BK virus large-T-antigen-coding sequences in normal human tissues and tumors of different histotypes.

Authors:  M De Mattei; F Martini; A Corallini; M Gerosa; K Scotlandi; P Carinci; G Barbanti-Brodano; M Tognon
Journal:  Int J Cancer       Date:  1995-06-09       Impact factor: 7.396

9.  Simian virus 40 in humans.

Authors:  Fernanda Martini; Alfredo Corallini; Veronica Balatti; Silvia Sabbioni; Cecilia Pancaldi; Mauro Tognon
Journal:  Infect Agent Cancer       Date:  2007-07-09       Impact factor: 2.965

10.  Antibody levels against BK virus and prostate, kidney and bladder cancers in the EPIC-Oxford cohort.

Authors:  R Newton; T Ribeiro; D Casabonne; E Alvarez; A Touzé; T Key; P Coursaget
Journal:  Br J Cancer       Date:  2005-11-28       Impact factor: 7.640

View more
  12 in total

1.  High prevalence of serum antibodies reacting with simian virus 40 capsid protein mimotopes in patients affected by malignant pleural mesothelioma.

Authors:  Elisa Mazzoni; Alfredo Corallini; Alfonso Cristaudo; Angelo Taronna; Gianfranco Tassi; Marco Manfrini; Manola Comar; Massimo Bovenzi; Roberto Guaschino; Francesca Vaniglia; Corrado Magnani; Ferruccio Casali; Giovanni Rezza; Giuseppe Barbanti-Brodano; Fernanda Martini; Mauro G Tognon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

2.  Significant prevalence of antibodies reacting with simian virus 40 mimotopes in sera from patients affected by glioblastoma multiforme.

Authors:  Elisa Mazzoni; Massimo Gerosa; Francesco Lupidi; Alfredo Corallini; Angelo Pio Taronna; Antonio D'Agostino; Massimo Bovenzi; Giuseppina Ruggeri; Ferruccio Casali; John Charles Rotondo; Giovanni Rezza; Giuseppe Barbanti-Brodano; Mauro Tognon; Fernanda Martini
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

3.  Identification of the neutralizing epitopes of Merkel cell polyomavirus major capsid protein within the BC and EF surface loops.

Authors:  Maxime J J Fleury; Jérôme T J Nicol; Mahtab Samimi; Françoise Arnold; Raphael Cazal; Raphaelle Ballaire; Olivier Mercey; Hélène Gonneville; Nicolas Combelas; Jean-Francois Vautherot; Thierry Moreau; Gérard Lorette; Pierre Coursaget; Antoine Touzé
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

4.  Significant low prevalence of antibodies reacting with simian virus 40 mimotopes in serum samples from patients affected by inflammatory neurologic diseases, including multiple sclerosis.

Authors:  Elisa Mazzoni; Silvia Pietrobon; Irene Masini; John Charles Rotondo; Mauro Gentile; Enrico Fainardi; Ilaria Casetta; Massimiliano Castellazzi; Enrico Granieri; Maria Luisa Caniati; Maria Rosaria Tola; Giovanni Guerra; Fernanda Martini; Mauro Tognon
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

5.  Serum IgG Antibodies from Pregnant Women Reacting to Mimotopes of Simian Virus 40 Large T Antigen, the Viral Oncoprotein.

Authors:  Elisa Mazzoni; Mariantonietta Di Stefano; Josè R Fiore; Federica Destro; Marco Manfrini; John Charles Rotondo; Maria V Casali; Fortunato Vesce; Pantaleo Greco; Gennaro Scutiero; Fernanda Martini; Mauro G Tognon
Journal:  Front Immunol       Date:  2017-04-10       Impact factor: 7.561

6.  Specific IgG Antibodies React to Mimotopes of BK Polyomavirus, a Small DNA Tumor Virus, in Healthy Adult Sera.

Authors:  Silvia Pietrobon; Ilaria Bononi; Elisa Mazzoni; Francesca Lotito; Marco Manfrini; Andrea Puozzo; Federica Destro; Giovanni Guerra; Pier Francesco Nocini; Fernanda Martini; Mauro G Tognon
Journal:  Front Immunol       Date:  2017-03-06       Impact factor: 7.561

Review 7.  New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma.

Authors:  Marika Rossini; Paola Rizzo; Ilaria Bononi; Anthony Clementz; Roberto Ferrari; Fernanda Martini; Mauro G Tognon
Journal:  Front Oncol       Date:  2018-04-03       Impact factor: 6.244

8.  Colorectal Carcinoma Affected Patients Are Significantly Poor Responders Against the Oncogenic JC Polyomavirus.

Authors:  Elena Torreggiani; Ilaria Bononi; Silvia Pietrobon; Elisa Mazzoni; Giovanni Guerra; Carlo Feo; Fernanda Martini; Mauro Tognon
Journal:  Front Immunol       Date:  2021-05-25       Impact factor: 7.561

9.  Serological evidence of an early seroconversion to Simian virus 40 in healthy children and adolescents.

Authors:  Angelo Taronna; Elisa Mazzoni; Alfredo Corallini; Ilaria Bononi; Silvia Pietrobon; Giovanni Guerra; Caterina Palmonari; Caterina Borgna-Pignatti; Manola Comar; Massimo Bovenzi; Ferruccio Casali; Roberto Marci; Giovanni Rezza; Giuseppe Barbanti-Brodano; Mauro Tognon; Fernanda Martini
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

10.  Specific Antibodies Reacting with SV40 Large T Antigen Mimotopes in Serum Samples of Healthy Subjects.

Authors:  Mauro Tognon; Alfredo Corallini; Marco Manfrini; Angelo Taronna; Janet S Butel; Silvia Pietrobon; Lorenzo Trevisiol; Ilaria Bononi; Emanuela Vaccher; Giuseppe Barbanti-Brodano; Fernanda Martini; Elisa Mazzoni
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.